These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 10967748)
41. [Recent topics on Alzheimer's disease. Alzheimer's disease from the viewpoint of the free radical theory]. Kobayashi K Nihon Rinsho; 1988 Jul; 46(7):1616-22. PubMed ID: 3221469 [No Abstract] [Full Text] [Related]
42. Diseases related to oxygen-derived free radicals. Knight JA Ann Clin Lab Sci; 1995; 25(2):111-21. PubMed ID: 7785961 [TBL] [Abstract][Full Text] [Related]
43. Is Alzheimer's disease a mitochondrial disorder? Cash AD; Perry G; Ogawa O; Raina AK; Zhu X; Smith MA Neuroscientist; 2002 Oct; 8(5):489-96. PubMed ID: 12374431 [TBL] [Abstract][Full Text] [Related]
44. Pathogenic factors in vascular dementia and Alzheimer's disease. Multiple actions of heparin that probably are beneficial. Engelberg H Dement Geriatr Cogn Disord; 2004; 18(3-4):278-98. PubMed ID: 15286460 [TBL] [Abstract][Full Text] [Related]
45. The Role of Mitochondrial Dysfunction in the Progression of Alzheimer's Disease. Desler C; Lillenes MS; Tønjum T; Rasmussen LJ Curr Med Chem; 2018; 25(40):5578-5587. PubMed ID: 28618998 [TBL] [Abstract][Full Text] [Related]
48. Antioxidants Rescue Mitochondrial Transport in Differentiated Alzheimer's Disease Trans-Mitochondrial Cybrid Cells. Yu Q; Fang D; Swerdlow RH; Yu H; Chen JX; Yan SS J Alzheimers Dis; 2016 Sep; 54(2):679-90. PubMed ID: 27567872 [TBL] [Abstract][Full Text] [Related]
49. Free radicals in Alzheimer's disease. Retz W; Gsell W; Münch G; Rösler M; Riederer P J Neural Transm Suppl; 1998; 54():221-36. PubMed ID: 9850931 [TBL] [Abstract][Full Text] [Related]
50. The significance of glucose turnover in the brain in the pathogenetic mechanisms of Alzheimer's disease. Meier-Ruge W; Bertoni-Freddari C Rev Neurosci; 1996; 7(1):1-19. PubMed ID: 8736675 [TBL] [Abstract][Full Text] [Related]
51. Reductionist science and Alzheimer's disease: redoubling our effort in redox chemistry. Wolozia B Mol Psychiatry; 1996 Nov; 1(5):352-5. PubMed ID: 9154224 [No Abstract] [Full Text] [Related]
52. Deleterious network hypothesis of Alzheimer's disease. Ying W Med Hypotheses; 1996 May; 46(5):421-8. PubMed ID: 8735880 [TBL] [Abstract][Full Text] [Related]
53. Free radicals and related reactive species as mediators of tissue injury and disease: implications for Health. Kehrer JP; Klotz LO Crit Rev Toxicol; 2015; 45(9):765-98. PubMed ID: 26610815 [TBL] [Abstract][Full Text] [Related]
54. Alzheimer's disease and oxygen radicals: new insights. Praticò D Biochem Pharmacol; 2002 Feb; 63(4):563-7. PubMed ID: 11992623 [TBL] [Abstract][Full Text] [Related]
55. Free radicals in brain metabolism and pathology. Evans PH Br Med Bull; 1993 Jul; 49(3):577-87. PubMed ID: 8221024 [TBL] [Abstract][Full Text] [Related]
56. Oxygen toxicity, free radicals and antioxidants in human disease: biochemical implications in atherosclerosis and the problems of premature neonates. Rice-Evans CA; Gopinathan V Essays Biochem; 1995; 29():39-63. PubMed ID: 9189713 [No Abstract] [Full Text] [Related]
57. Oxygen radicals and neuropsychiatric illness. Some speculations. Lohr JB Arch Gen Psychiatry; 1991 Dec; 48(12):1097-106. PubMed ID: 1845228 [TBL] [Abstract][Full Text] [Related]
58. [Coronary heart disease--a free radical associated disease? What is the value of antioxidant substances?]. Döll M Med Monatsschr Pharm; 1997 Mar; 20(3):66-70. PubMed ID: 9162837 [No Abstract] [Full Text] [Related]
59. [Free radicals and antioxidants. Advantages of antioxidants in clinical medicine, truth or fiction?]. Huttunen J Duodecim; 1994; 110(17):1606-8. PubMed ID: 7497991 [No Abstract] [Full Text] [Related]
60. Free radical damage, iron, and Alzheimer's disease. Smith MA; Perry G J Neurol Sci; 1995 Dec; 134 Suppl():92-4. PubMed ID: 8847550 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]